purchase customization

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Mammography CAD
1.2.3 MRI CAD
1.2.4 PET/CT CAD
1.2.5 Ultrasound CAD
1.3 Market by Application
1.3.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Clinics
1.3.3 Hospital
1.3.4 Medical Examination Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Perspective (2017-2028)
2.2 Computer-aided Detection (CAD) for Breast Cancer Screening Growth Trends by Region
2.2.1 Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Computer-aided Detection (CAD) for Breast Cancer Screening Historic Market Size by Region (2017-2022)
2.2.3 Computer-aided Detection (CAD) for Breast Cancer Screening Forecasted Market Size by Region (2023-2028)
2.3 Computer-aided Detection (CAD) for Breast Cancer Screening Market Dynamics
2.3.1 Computer-aided Detection (CAD) for Breast Cancer Screening Industry Trends
2.3.2 Computer-aided Detection (CAD) for Breast Cancer Screening Market Drivers
2.3.3 Computer-aided Detection (CAD) for Breast Cancer Screening Market Challenges
2.3.4 Computer-aided Detection (CAD) for Breast Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computer-aided Detection (CAD) for Breast Cancer Screening Players by Revenue
3.1.1 Global Top Computer-aided Detection (CAD) for Breast Cancer Screening Players by Revenue (2017-2022)
3.1.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Revenue Market Share by Players (2017-2022)
3.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Computer-aided Detection (CAD) for Breast Cancer Screening Revenue
3.4 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Concentration Ratio
3.4.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computer-aided Detection (CAD) for Breast Cancer Screening Revenue in 2021
3.5 Computer-aided Detection (CAD) for Breast Cancer Screening Key Players Head office and Area Served
3.6 Key Players Computer-aided Detection (CAD) for Breast Cancer Screening Product Solution and Service
3.7 Date of Enter into Computer-aided Detection (CAD) for Breast Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Computer-aided Detection (CAD) for Breast Cancer Screening Breakdown Data by Type
4.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Historic Market Size by Type (2017-2022)
4.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Forecasted Market Size by Type (2023-2028)
5 Computer-aided Detection (CAD) for Breast Cancer Screening Breakdown Data by Application
5.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Historic Market Size by Application (2017-2022)
5.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Computer-aided Detection (CAD) for Breast Cancer Screening Market Size (2017-2028)
6.2 North America Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2017-2022)
6.3 North America Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Market Size (2017-2028)
7.2 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2017-2022)
7.3 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Market Size (2017-2028)
8.2 Asia-Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2017-2022)
8.3 Asia-Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Computer-aided Detection (CAD) for Breast Cancer Screening Market Size (2017-2028)
9.2 Latin America Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2017-2022)
9.3 Latin America Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Market Size (2017-2028)
10.2 Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2017-2022)
10.3 Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 CureMetrix, Inc.
11.1.1 CureMetrix, Inc. Company Detail
11.1.2 CureMetrix, Inc. Business Overview
11.1.3 CureMetrix, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.1.4 CureMetrix, Inc. Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2017-2022)
11.1.5 CureMetrix, Inc. Recent Development
11.2 FUJIFILM Corporation
11.2.1 FUJIFILM Corporation Company Detail
11.2.2 FUJIFILM Corporation Business Overview
11.2.3 FUJIFILM Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.2.4 FUJIFILM Corporation Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2017-2022)
11.2.5 FUJIFILM Corporation Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.3.4 GE Healthcare Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2017-2022)
11.3.5 GE Healthcare Recent Development
11.4 Hitachi, Ltd.
11.4.1 Hitachi, Ltd. Company Detail
11.4.2 Hitachi, Ltd. Business Overview
11.4.3 Hitachi, Ltd. Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.4.4 Hitachi, Ltd. Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2017-2022)
11.4.5 Hitachi, Ltd. Recent Development
11.5 Hologic, Inc.
11.5.1 Hologic, Inc. Company Detail
11.5.2 Hologic, Inc. Business Overview
11.5.3 Hologic, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.5.4 Hologic, Inc. Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2017-2022)
11.5.5 Hologic, Inc. Recent Development
11.6 iCAD Inc.
11.6.1 iCAD Inc. Company Detail
11.6.2 iCAD Inc. Business Overview
11.6.3 iCAD Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.6.4 iCAD Inc. Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2017-2022)
11.6.5 iCAD Inc. Recent Development
11.7 IMS Giotto SpA
11.7.1 IMS Giotto SpA Company Detail
11.7.2 IMS Giotto SpA Business Overview
11.7.3 IMS Giotto SpA Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.7.4 IMS Giotto SpA Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2017-2022)
11.7.5 IMS Giotto SpA Recent Development
11.8 Konica Minolta
11.8.1 Konica Minolta Company Detail
11.8.2 Konica Minolta Business Overview
11.8.3 Konica Minolta Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.8.4 Konica Minolta Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2017-2022)
11.8.5 Konica Minolta Recent Development
11.9 McKesson Corporation
11.9.1 McKesson Corporation Company Detail
11.9.2 McKesson Corporation Business Overview
11.9.3 McKesson Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.9.4 McKesson Corporation Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2017-2022)
11.9.5 McKesson Corporation Recent Development
11.10 Merge Healthcare (IBM Corporation)
11.10.1 Merge Healthcare (IBM Corporation) Company Detail
11.10.2 Merge Healthcare (IBM Corporation) Business Overview
11.10.3 Merge Healthcare (IBM Corporation) Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.10.4 Merge Healthcare (IBM Corporation) Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2017-2022)
11.10.5 Merge Healthcare (IBM Corporation) Recent Development
11.11 Neusoft Corporation
11.11.1 Neusoft Corporation Company Detail
11.11.2 Neusoft Corporation Business Overview
11.11.3 Neusoft Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.11.4 Neusoft Corporation Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2017-2022)
11.11.5 Neusoft Corporation Recent Development
11.12 Qlarity Imaging, LLC
11.12.1 Qlarity Imaging, LLC Company Detail
11.12.2 Qlarity Imaging, LLC Business Overview
11.12.3 Qlarity Imaging, LLC Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.12.4 Qlarity Imaging, LLC Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2017-2022)
11.12.5 Qlarity Imaging, LLC Recent Development
11.13 Siemens Healthineers AG
11.13.1 Siemens Healthineers AG Company Detail
11.13.2 Siemens Healthineers AG Business Overview
11.13.3 Siemens Healthineers AG Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.13.4 Siemens Healthineers AG Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2017-2022)
11.13.5 Siemens Healthineers AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details